News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Opinion|Videos|October 9, 2024 (Updated: October 9, 2024)

Transforming MDD: A Patient's Journey with Rapid-Acting Therapy

A patient suffering from MDD, shares his story and the rapid benefits of patient experience with NMDA-targeted therapy, commenting on the tremendous quality of life benefit.

Episodes in this series

EP. 1 Expert Insights into Navigating MDD Prevalence, Stigma, and Treatment Challenges for Improved Patient Outcomes

EP. 1 Expert Insights into Navigating MDD Prevalence, Stigma, and Treatment Challenges for Improved Patient Outcomes

EP. 2 Advancing MDD Treatment: From STAR*D Insights to Precision Medicine and Novel Therapeutics

EP. 2 Advancing MDD Treatment: From STAR*D Insights to Precision Medicine and Novel Therapeutics

EP. 3 Commentary on Redefining Depression Management with Updated Treatment Strategies

EP. 3 Commentary on Redefining Depression Management with Updated Treatment Strategies

EP. 4 Navigating Non-Response: A Holistic Approach to Patient Care

EP. 4 Navigating Non-Response: A Holistic Approach to Patient Care

EP. 5 Transforming MDD: A Patient's Journey with Rapid-Acting Therapy

EP. 5 Transforming MDD: A Patient's Journey with Rapid-Acting Therapy

EP. 6 Quantifying Success: Measuring Depth of Treatment Response in MDD

EP. 6 Quantifying Success: Measuring Depth of Treatment Response in MDD

EP. 7 Access Challenges: Bridging Insurance Gaps for MDD Innovations

EP. 7 Access Challenges: Bridging Insurance Gaps for MDD Innovations

EP. 8 Depression Treatment: Expert Guide to Medication Management & Therapeutic Success

EP. 8 Depression Treatment: Expert Guide to Medication Management & Therapeutic Success

EP. 9 From Neuroplasticity to Patient Conversations: Managing Affective Disorders Effectively

EP. 9 From Neuroplasticity to Patient Conversations: Managing Affective Disorders Effectively

EP. 10 Managing Persistent MDD: Case Studies and Treatment Challenges

EP. 10 Managing Persistent MDD: Case Studies and Treatment Challenges

EP. 11 Evaluating Treatment Failure and Symptomatic Remission in MDD

EP. 11 Evaluating Treatment Failure and Symptomatic Remission in MDD

EP. 12 Exploring Rapid-Acting Therapies in MDD: Pharmacodynamics and Treatment Evolution

EP. 12 Exploring Rapid-Acting Therapies in MDD: Pharmacodynamics and Treatment Evolution

EP. 13 Addressing Unsatisfactory Responses in Chronic MDD

EP. 13 Addressing Unsatisfactory Responses in Chronic MDD

EP. 14 Defining and Managing Treatment-Resistant Depression: Efficacy and Real-World Insights

EP. 14 Defining and Managing Treatment-Resistant Depression: Efficacy and Real-World Insights

EP. 15 Optimizing Treatment Response: Insights from Clinical Data and Real-World Experience

EP. 15 Optimizing Treatment Response: Insights from Clinical Data and Real-World Experience

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related Content

Screening for MDD: Distinguishing Depression From Grief and Medical Mimics

ByGus Alva, MD ,Anita H. Clayton, MD,Charles Debattista, MD,Lara Shirikjian, MD ,Hara Oyedeji, DNP, PMHNP-BC

July 28th 2026

Recognizing MDD in Practice: Presentation, Risk Factors, and Delayed Diagnosis

ByGus Alva, MD ,Anita H. Clayton, MD,Charles Debattista, MD,Lara Shirikjian, MD ,Hara Oyedeji, DNP, PMHNP-BC

July 28th 2026

Experts featured in this series.

Multidisciplinary Approaches to Long-Term Narcolepsy Care

ByKarl Doghramji, MD, FAASM, DFAPA,Michael Strunc, MD,Ellen Wermter, FNP-BC, DBSM, FAASM,W. Christopher Winter, MD

April 22nd 2026

Experts featured in this series.

Optimizing Narcolepsy Treatment Through Polypharmacy

ByKarl Doghramji, MD, FAASM, DFAPA,Michael Strunc, MD,Ellen Wermter, FNP-BC, DBSM, FAASM,W. Christopher Winter, MD

April 15th 2026

Experts featured in this series.

Assessing DEA Scheduling and Emerging Therapies in Narcolepsy

ByKarl Doghramji, MD, FAASM, DFAPA,Michael Strunc, MD,Ellen Wermter, FNP-BC, DBSM, FAASM,W. Christopher Winter, MD

April 15th 2026

Latest CME

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Trending on Psychiatric Times

FDA Approves Centanafadine for ADHD in Children, Adolescents, and Adults

Quiet Comfort: New Details on COMP360 Psilocybin Administration Sessions for the Treatment of PTSD

Attachment-Based Therapy in Adolescent Substance Users: A Meta-Synthesis of Emotional Isolation and Avoidant Attachment Patterns

What Designing AI Taught Me About Why Psychiatrists Ignore It

Preventing Alzheimer Disease After Brain Injury: Targeting TNF With XPro1595